Logo image of AREIT.PA

ALTAREIT (AREIT.PA) Stock Fundamental Analysis

Europe - EPA:AREIT - FR0000039216 - Common Stock

530 EUR
0 (0%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

2

Overall AREIT gets a fundamental rating of 2 out of 10. We evaluated AREIT against 72 industry peers in the Real Estate Management & Development industry. AREIT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AREIT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AREIT had negative earnings in the past year.
In the past year AREIT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AREIT reported negative net income in multiple years.
Of the past 5 years AREIT 4 years had a positive operating cash flow.
AREIT.PA Yearly Net Income VS EBIT VS OCF VS FCFAREIT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

AREIT has a Return On Assets of -1.84%. This is in the lower half of the industry: AREIT underperforms 63.89% of its industry peers.
With a Return On Equity value of -8.22%, AREIT is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
The Return On Invested Capital of AREIT (1.02%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.84%
ROE -8.22%
ROIC 1.02%
ROA(3y)-2.85%
ROA(5y)-1.06%
ROE(3y)-14.56%
ROE(5y)-5.87%
ROIC(3y)N/A
ROIC(5y)N/A
AREIT.PA Yearly ROA, ROE, ROICAREIT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 0.93%, AREIT is in line with its industry, outperforming 40.28% of the companies in the same industry.
AREIT's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 16.64%, AREIT is not doing good in the industry: 68.06% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of AREIT has declined.
Industry RankSector Rank
OM 0.93%
PM (TTM) N/A
GM 16.64%
OM growth 3Y-50.62%
OM growth 5Y-32.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-5.31%
AREIT.PA Yearly Profit, Operating, Gross MarginsAREIT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AREIT is destroying value.
Compared to 1 year ago, AREIT has about the same amount of shares outstanding.
The number of shares outstanding for AREIT remains at a similar level compared to 5 years ago.
Compared to 1 year ago, AREIT has a worse debt to assets ratio.
AREIT.PA Yearly Shares OutstandingAREIT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
AREIT.PA Yearly Total Debt VS Total AssetsAREIT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.39, we must say that AREIT is in the distress zone and has some risk of bankruptcy.
AREIT has a better Altman-Z score (1.39) than 70.83% of its industry peers.
AREIT has a debt to FCF ratio of 4.57. This is a neutral value as AREIT would need 4.57 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 4.57, AREIT belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
AREIT has a Debt/Equity ratio of 0.96. This is a neutral value indicating AREIT is somewhat dependend on debt financing.
The Debt to Equity ratio of AREIT (0.96) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 4.57
Altman-Z 1.39
ROIC/WACC0.17
WACC5.96%
AREIT.PA Yearly LT Debt VS Equity VS FCFAREIT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

AREIT has a Current Ratio of 1.22. This is a normal value and indicates that AREIT is financially healthy and should not expect problems in meeting its short term obligations.
AREIT's Current ratio of 1.22 is in line compared to the rest of the industry. AREIT outperforms 47.22% of its industry peers.
AREIT has a Quick Ratio of 1.22. This is a bad value and indicates that AREIT is not financially healthy enough and could expect problems in meeting its short term obligations.
AREIT has a Quick ratio (0.74) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.74
AREIT.PA Yearly Current Assets VS Current LiabilitesAREIT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

0

3. Growth

3.1 Past

AREIT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.00%, which is quite impressive.
AREIT shows a decrease in Revenue. In the last year, the revenue decreased by -6.91%.
Measured over the past years, AREIT shows a decrease in Revenue. The Revenue has been decreasing by -3.00% on average per year.
EPS 1Y (TTM)82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.86%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-4.16%
Revenue growth 5Y-3%
Sales Q2Q%-23.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AREIT.PA Yearly Revenue VS EstimatesAREIT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AREIT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AREIT.PA Price Earnings VS Forward Price EarningsAREIT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AREIT is valued a bit cheaper than 63.89% of the companies in the same industry.
81.94% of the companies in the same industry are more expensive than AREIT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.14
EV/EBITDA 20.19
AREIT.PA Per share dataAREIT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800 1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AREIT!.
Industry RankSector Rank
Dividend Yield N/A

ALTAREIT

EPA:AREIT (10/14/2025, 7:00:00 PM)

530

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-29 2025-07-29
Earnings (Next)02-23 2026-02-23
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.85%
Ins Owner ChangeN/A
Market Cap927.50M
Analysts78
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF 5.14
P/OCF 3.87
P/B 1.3
P/tB 2.43
EV/EBITDA 20.19
EPS(TTM)-33.52
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)103.09
FCFY19.45%
OCF(TTM)136.86
OCFY25.82%
SpS1269.89
BVpS407.6
TBVpS218.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.84%
ROE -8.22%
ROCE 1.65%
ROIC 1.02%
ROICexc 1.17%
ROICexgc 1.57%
OM 0.93%
PM (TTM) N/A
GM 16.64%
FCFM 8.12%
ROA(3y)-2.85%
ROA(5y)-1.06%
ROE(3y)-14.56%
ROE(5y)-5.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-39.13%
ROICexcg growth 5Y-24.87%
ROICexc growth 3Y-44.01%
ROICexc growth 5Y-28.25%
OM growth 3Y-50.62%
OM growth 5Y-32.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-5.31%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 4.57
Debt/EBITDA 10.34
Cap/Depr 130.75%
Cap/Sales 2.66%
Interest Coverage 0.3
Cash Conversion 363.43%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.74
Altman-Z 1.39
F-Score6
WACC5.96%
ROIC/WACC0.17
Cap/Depr(3y)26.41%
Cap/Depr(5y)37.36%
Cap/Sales(3y)0.42%
Cap/Sales(5y)0.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-4.16%
Revenue growth 5Y-3%
Sales Q2Q%-23.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y106.53%
EBIT growth 3Y-52.68%
EBIT growth 5Y-34.13%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.86%
FCF growth 3Y76.04%
FCF growth 5Y6.06%
OCF growth 1Y126.59%
OCF growth 3Y70.6%
OCF growth 5Y7.85%